Deal Police deliver donations to Tinton Falls Humane Society after successful holiday fundraiser December 28, 2024
Former Director of Humane Society of the Nature Coast Sentenced to Prison for Money Laundering and Fraud October 15, 2023October 15, 2023
University Leaders Give Green Light To New School Dedicated To ‘Free Society’ Principles May 5, 2023May 4, 2023
RFK Jr. Says ‘Mega-Billionaires’ Are Using Climate Change To Usher In ‘Totalitarian Controls’ On Society April 29, 2023
FORMER TREASURER OF PERRY COUNTY AGRICULTURAL SOCIETY SENTENCED TO 21 MONTHS IN FEDERAL PRISON FOR FRAUD July 27, 2022
Bausch + Lomb Announces Scientific Data on XIPERE® (Triamcinolone Acetonide Injectable Suspension) to be Presented During the American Society of Retina Specialists Annual Scientific Meeting July 6, 2022
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English June 5, 2022
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English Deutschland – Deutsch June 4, 2022
Jubilant Therapeutics Inc. berichtet auf der Jahrestagung 2022 der American Society of Clinical Oncology (ASCO) über die Entwicklung oral verfügbarer und ins Gehirn eindringender niedermolekularer PD-L1-Inhibitoren Deutschland – Deutsch USA – English France – Français June 4, 2022
